Skip to main content

Advancing pancreatic cancer research and care

November 9, 2020

Pancreatic cancer is an extremely challenging cancer to treat and has an increasing incidence in the United States. Fortunately, pancreatic cancer research is being conducted at UNC Lineberger.

Der named AAAS Fellow

November 26, 2019

The honor recognizes Der’s contributions to cancer research. His lab’s recent findings on pancreatic cancer have led to clinical studies of a new treatment.

Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment

November 18, 2019

The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.

Der lab finds promising drug to fight pancreatic cancer

May 9, 2016

In the lab of Channing Der, PhD, researchers believe they have found a promising strategy to target a type of pancreatic cancer that is notoriously resistant to treatment—pancreatic cancer that has a mutation in a gene called KRAS.